Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 13.45
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks.
Data is available to registered users only
